2008
DOI: 10.1016/j.febslet.2008.04.039
|View full text |Cite
|
Sign up to set email alerts
|

Rho GTPases in cancer cell biology

Abstract: Rho GTPases contribute to multiple cellular processes that could affect cancer progression, including cytoskeletal dynamics, cell cycle progression, transcriptional regulation, cell survival and vesicle trafficking. In vitro several Rho GTPases have oncogenic activity and/or can promote cancer cell invasion, and this correlates with increased expression and activity in a variety of cancers. Conversely, other family members appear to act as tumour suppressors and are deleted, mutated or downregulated in some ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
646
2
15

Year Published

2010
2010
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 703 publications
(672 citation statements)
references
References 90 publications
9
646
2
15
Order By: Relevance
“…Rho-family GTPases influence a plethora cellular activity, including cell polarity and migration, as well as cancer cell growth and progression (Vega and Ridley, 2008). These GTPases are monomeric 20-30 kDa GTPbinding proteins and function as molecular switches by altering between active GTP-bound and inactive GDPbound forms (Bar-Sagi and Hall, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Rho-family GTPases influence a plethora cellular activity, including cell polarity and migration, as well as cancer cell growth and progression (Vega and Ridley, 2008). These GTPases are monomeric 20-30 kDa GTPbinding proteins and function as molecular switches by altering between active GTP-bound and inactive GDPbound forms (Bar-Sagi and Hall, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the outlined 3D-SPT method and trajectory classification would be a highly desirable tool for monitoring EGFR intracellular trafficking dynamics at distinct phenotypic transition stages in cancer development. Additionally, our study may also provide a unique means to identify how the therapeutic drugs (such as monoclonal antibodies and tyrosine kinase inhibitors) affect receptor dynamics (anywhere from actin network reorganization (121) to derailed endocytosis (119)), which could have significant impact in the treatment of cancer. …”
Section: Outlook Of High-resolution 3d Tracking Of Egfrmentioning
confidence: 99%
“…Guanine nucleotide-dissociation inhibitors sequester and maintain inactive Rho GTPases in the cytoplasm (Van Aelst and D'Souza-Schorey, 1997). Many lines of evidence now show that Rho GTPases are involved in cancer initiation and progression (Vega and Ridley, 2008). However, unlike mutational activation of Ras that is observed in many human cancers, it appears that it is the expression of Rho proteins and their regulators that is altered in many cancer types (GoÂŽmez del Pulgar et al, 2005).…”
Section: Introductionmentioning
confidence: 99%